MiNK Therapeutics Director Peter Behner Receives Award (RSUs)

What Happened

• Director Peter Behner received a grant of 1,485 restricted stock units (RSUs) on 2026-09-01. The RSUs are valued at $10.95 per share, for a total reported value of $16,261. These RSUs were awarded in lieu of cash retainers for board and committee compensation and will convert into one share per RSU upon vesting.

Key Details

• Transaction date: 2026-09-01; Filing date with SEC: 2026-09-02 (timely filing).
• Grant type/code: Award/Grant (code A).
• Shares/units granted: 1,485 RSUs at $10.95 per share; total value $16,261 (per filing).
• Vesting: RSUs vest one month from the grant date (around 2026-10-01).
• Shares owned after transaction: Not reported in the provided filing.
• Footnote: RSUs represent a contingent right to receive one share of common stock for each RSU; received in lieu of cash retainers.

Context

• RSU grants are compensation, not an open-market purchase or sale. They typically convert into shares at vesting and may be subject to company-imposed restrictions until that time. Such awards are common for directors and reflect compensation practices rather than an explicit buy/sell signal.